Showing results (131-140 of 166) with videos related to
Sort By:
Pageof 17
Cancer Research|May 2, 2013
SENP1 deSUMOylates and regulates Pin1 protein activity and cellular functionChun-Hau Chen, Che-Chang Chang, Tae Ho Lee, et al.Cerebral Cortex (New York, N.Y. : 1991)|February 11, 2021
The Pin1-CaMKII-AMPA Receptor Axis Regulates Epileptic SusceptibilityXiaojun Hou, Fan Yang, Angcheng Li, et al.Cancer Research|May 3, 2014
Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancerMan-Li Luo, Chang Gong, Chun-Hau Chen, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
Simultaneous brain-wide single-cell recording resolves spatiotemporal memory architectureDongqing Shi, Yongjie Hou, Yixiao Yan, et al.Scientific Reports|March 7, 2017
Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathwaysXin-Hua Liao, Arina Li Zhang, Min Zheng, et al.Molecular and Cellular Biology|November 9, 2011
Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1Prashant Rajbhandari, Greg Finn, Natalia M Solodin, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 25, 2017
A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathwaysDayun Yang, Wensong Luo, Jichuang Wang, et al.Scientific Reports|April 7, 2017
MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathwaysXingxue Yan, Zhendong Zhu, Shenmin Xu, et al.Alzheimer Disease and Associated Disorders|October 23, 2025
Evaluation of Polygenic Risk Scores for a Possible Genetic Basis of the Inverse Association Between Cancer and Cognitive DeclineRebecca E Graff, Dorothy M Chen, Kaitlin N Swinnerton, et al.Cancer Research|March 21, 2020
Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP InhibitionMan-Li Luo, Fang Zheng, Wenying Chen, et al.Pageof 17